All Stories

  1. Can acute stress be fatal? A systematic cross-disciplinary review

    Article • Stress, February 2019, Taylor & Francis

    Kari Saunamaki

  2. Long-term outcome of FFR-guided PCI for stable coronary artery disease in daily clinical practice: a propensity score-matched landmark analysis

    Article • EuroIntervention, February 2016, Europa Digital & Publishing

    Kari Saunamaki

  3. Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to “mega centre” for patients with ST-segment elevation myocardial infarction

    Article • EuroIntervention, September 2015, Europa Digital & Publishing

    Kari Saunamaki

  4. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial

    Article • The Lancet, August 2015, Elsevier

    Kari Saunamaki

  5. Angiographic Characteristics of Intermediate Stenosis of the Left Anterior Descending Artery for Determination of Lesion Significance as Identified by Fractional Flow Reserve

    Article • The American Journal of Cardiology, June 2015, Elsevier

    Kari Saunamaki

  6. Predictors and prognostic value of left atrial remodelling after acute myocardial infarction

    Article • Open Heart, June 2015, BMJ

    Kari Saunamaki

  7. Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudy

    Article • The International Journal of Cardiovascular Imaging, February 2015, Springer Science + Business Media

    Kari Saunamaki

  8. How should I treat subacute stent thrombosis in the context of brain haemorrhage with abciximab?

    Article • EuroIntervention, February 2015, Europa Digital & Publishing

    Kari Saunamaki

  9. Prehospital administration of P2Y12 inhibitors and early coronary reperfusion in primary PCI: an observational comparative study

    Article • Thrombosis and Haemostasis, January 2015, Thieme Publishing Group

    Kari Saunamaki

  10. Stent Thrombosis is the Primary Cause of ST-Segment Elevation Myocardial Infarction following Coronary Stent Implantation: A Five Year Follow-Up of the SORT OUT II Study

    Article • PLoS ONE, November 2014, PLOS

    Kari Saunamaki

  11. Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI

    Article • Journal of the American College of Cardiology, November 2014, Elsevier

    Kari Saunamaki

  12. Tailored antiplatelet therapy to improve prognosis in patients exhibiting clopidogrel low-response prior to percutaneous coronary intervention for stable angina or non-ST elevation acute coronary syndrome

    Article • Platelets, August 2014, Taylor & Francis

    Kari Saunamaki

  13. ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial

    Article • EuroIntervention, August 2014, Europa Digital & Publishing

    Kari Saunamaki

  14. The impact of distal embolization and distal protection on long-term outcome in patients with ST elevation myocardial infarction randomized to primary percutaneous coronary intervention – results from a randomized study

    Article • European Heart Journal Acute Cardiovascular Care, July 2014, SAGE Publications

    Kari Saunamaki

  15. Hyperglycemia and Infarct Size in STEMI Patients: The Role of Exenatide

    Article • Diabetes, June 2014, American Diabetes Association

    Kari Saunamaki

  16. Biolimus-Eluting Stents With Biodegradable Polymer Versus Bare-Metal Stents in Acute Myocardial Infarction

    Article • Circulation Cardiovascular Interventions, June 2014, Wolters Kluwer Health

    Kari Saunamaki

  17. A mismatch index based on the difference between measured left ventricular ejection fraction and that estimated by infarct size at three months following reperfused acute myocardial infarction

    Article • Journal of Electrocardiology, March 2014, Elsevier

    Kari Saunamaki

  18. Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stents

    Article • Scandinavian Cardiovascular Journal, February 2014, Taylor & Francis

    Professor Jens Flensted Lassen, Kari Saunamaki

  19. Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation

    Article • EuroIntervention, January 2014, Europa Digital & Publishing

    Kari Saunamaki

  20. Prasugrel or double-dose clopidogrel to overcome clopidogrel low-response – The TAILOR (Thrombocytes And IndividuaLization of ORal antiplatelet therapy in percutaneous coronary intervention) randomized trial

    Article • Platelets, November 2013, Taylor & Francis

    Kari Saunamaki

  21. Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study

    Article • European Heart Journal, October 2013, European Society of Cardiology

    Kari Saunamaki

  22. Intravascular ultrasound assessed incomplete stent apposition and stent fracture in stent thrombosis after bare metal versus drug-eluting stent treatment the Nordic Intravascular Ultrasound Study (NIVUS)

    Article • International Journal of Cardiology, September 2013, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  23. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: Five-year results from the ZOMAXX I trial

    Article • Catheterization and Cardiovascular Interventions, July 2013, Wiley

    Kari Saunamaki

  24. Search and rescue helicopter-assisted transfer of ST-elevation myocardial infarction patients from an island in the Baltic Sea: results from over 100 rescue missions

    Article • Emergency Medicine Journal, July 2013, BMJ

    Kari Saunamaki

  25. Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction

    Article • JACC Cardiovascular Interventions, June 2013, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  26. Hypercoagulation Assessed by Thromboelastography is Neither Related to Infarct Size nor to Clinical Outcome After Primary Percutaneous Coronary Intervention

    Article • Clinical and Applied Thrombosis/Hemostasis, April 2013, SAGE Publications

    Kari Saunamaki

  27. Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study

    Article • EuroIntervention, February 2013, Europa Digital & Publishing

    Kari Saunamaki

  28. Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study

    Article • European Heart Journal - Cardiovascular Imaging, November 2012, European Society of Cardiology

    Kari Saunamaki

  29. ST peak during primary percutaneous coronary intervention predicts final infarct size, left ventricular function, and clinical outcome

    Article • Journal of Electrocardiology, November 2012, Elsevier

    Kari Saunamaki

  30. Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with ST-segment elevation myocardial infarction

    Article • American Heart Journal, October 2012, Elsevier

    Kari Saunamaki

  31. Virtual Histology Assessment of Cardiac Allograft Vasculopathy Following Introduction of Everolimus—Results of a Multicenter Trial

    Article • American Journal of Transplantation, October 2012, Elsevier

    Kari Saunamaki

  32. Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction

    Article • JAMA, August 2012, American Medical Association (AMA)

    Kari Saunamaki

  33. Comparison of Selvester QRS score with magnetic resonance imaging measured infarct size in patients with ST elevation myocardial infarction

    Article • Journal of Electrocardiology, July 2012, Elsevier

    Kari Saunamaki

  34. Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance study

    Article • European Heart Journal - Cardiovascular Imaging, June 2012, European Society of Cardiology

    Kari Saunamaki

  35. Exenatide Reduces Final Infarct Size in Patients With ST-Segment–Elevation Myocardial Infarction and Short-Duration of Ischemia

    Article • Circulation Cardiovascular Interventions, April 2012, Wolters Kluwer Health

    Kari Saunamaki

  36. Influence of pre-infarction angina, collateral flow, and pre-procedural TIMI flow on myocardial salvage index by cardiac magnetic resonance in patients with ST-segment elevation myocardial infarction

    Article • European Heart Journal - Cardiovascular Imaging, December 2011, European Society of Cardiology

    Kari Saunamaki

  37. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

    Article • European Heart Journal, September 2011, European Society of Cardiology

    Kari Saunamaki

  38. Effect of Everolimus Introduction on Cardiac Allograft Vasculopathy—Results of a Randomized, Multicenter Trial

    Article • Transplantation, July 2011, Wolters Kluwer Health

    Kari Saunamaki

  39. Optical coherence tomography at follow-up after percutaneous coronary intervention: relationship between procedural dissections, stent strut malapposition and stent healing

    Article • EuroIntervention, July 2011, Europa Digital & Publishing

    Kari Saunamaki

  40. Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial

    Article • European Heart Journal, June 2011, European Society of Cardiology

    Dr E Regar, Kari Saunamaki

  41. Usefulness of Preprocedure High-Sensitivity C-Reactive Protein to Predict Death, Recurrent Myocardial Infarction, and Stent Thrombosis According to Stent Type in Patients With ST-Segment Elevation Myocardial Infarction Randomized to Bare Metal or Drug-...

    Article • The American Journal of Cardiology, June 2011, Elsevier

    Kari Saunamaki

  42. ST-Segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance

    Article • American Heart Journal, December 2010, Elsevier

    Kari Saunamaki

  43. Sirolimus-eluting versus bare-metal stent implantation in patients with ostial lesions

    Article • International Journal of Cardiology, November 2010, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  44. Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction

    Article • Journal of the American College of Cardiology, August 2010, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  45. Cardioprotective Effects of Ischemic Postconditioning in Patients Treated With Primary Percutaneous Coronary Intervention, Evaluated by Magnetic Resonance

    Article • Circulation Cardiovascular Interventions, February 2010, Wolters Kluwer Health

    Kari Saunamaki

  46. Long-term effects of invasive treatment in patients with a post-thrombolytic Q-wave myocardial infarction

    Article • Scandinavian Cardiovascular Journal, January 2010, Taylor & Francis

    Kari Saunamaki

  47. Systemic Drugs for Restenosis Prevention: Old Idea, New Drugs

    Article • Cardiology, January 2010, Karger Publishers

    Kari Saunamaki

  48. Long-Term Prognosis in an ST-Segment Elevation Myocardial Infarction Population Treated With Routine Primary Percutaneous Coronary Intervention

    Article • Circulation Cardiovascular Interventions, October 2009, Wolters Kluwer Health

    Kari Saunamaki

  49. Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

    Article • New England Journal of Medicine, January 2009, New England Journal of Medicine (NEJM/MMS)

    Kari Saunamaki

  50. Restenosis in coronary bare metal stents. Importance of time to follow-up: A comparison of coronary angiograms 6 months and 4 years after implantation

    Article • Scandinavian Cardiovascular Journal, January 2009, Taylor & Francis

    Kari Saunamaki

  51. Drug-Eluting Versus Bare Metal Stents in Patients With ST-Segment–Elevation Myocardial Infarction

    Article • Circulation, September 2008, Wolters Kluwer Health

    Kari Saunamaki

  52. Long-term outcome of primary angioplasty compared with fibrinolysis across age groups: A Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI-2) substudy

    Article • American Heart Journal, August 2008, Elsevier

    Kari Saunamaki

  53. Long-Term Outcome in Patients Treated With Sirolimus-Eluting Stents in Complex Coronary Artery Lesions

    Article • Journal of the American College of Cardiology, May 2008, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  54. Randomized Comparison of Distal Protection Versus Conventional Treatment in Primary Percutaneous Coronary Intervention

    Article • Journal of the American College of Cardiology, March 2008, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  55. Comparison of Paclitaxel- and Sirolimus-Eluting Stents in Everyday Clinical Practice

    Article • JAMA, January 2008, American Medical Association (AMA)

    Professor Jens Flensted Lassen, Kari Saunamaki

  56. 7,528 Patients Treated with PCI – A Scandinavian Real-Life Scenario

    Article • Cardiology, October 2007, Karger Publishers

    Kari Saunamaki

  57. Prognostic Evaluation by Clinical Exercise Test Scores in Patients Treated With Primary Percutaneous Coronary Intervention or Fibrinolysis for Acute Myocardial Infarction (a Danish Trial in Acute Myocardial Infarction-2 Sub-Study)

    Article • The American Journal of Cardiology, October 2007, Elsevier

    Kari Saunamaki

  58. Pre-Discharge Exercise Test for Evaluation of Patients with Complete or Incomplete Revascularization following Primary Percutaneous Coronary Intervention: A DANAMI-2 Sub-Study

    Article • Cardiology, August 2007, Karger Publishers

    Kari Saunamaki

  59. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: Subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT)

    Article • American Heart Journal, December 2006, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  60. Revascularization Compared to Medical Treatment in Patients with Silent vs. Symptomatic Residual Ischemia after Thrombolyzed Myocardial Infarction – The DANAMI Study

    Article • Cardiology, November 2006, Karger Publishers

    Kari Saunamaki

  61. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions

    Article • American Heart Journal, November 2006, Elsevier

    Kari Saunamaki

  62. Percutaneous treatment of coronary bifurcation lesions: a novel "extended Y" technique with complete lesion stent coverage

    Article • Heart, May 2006, BMJ

    Kari Saunamaki

  63. Virtual histology and the hunt for the vulnerable plaque

    Article • European Heart Journal, April 2006, European Society of Cardiology

    Kari Saunamaki

  64. The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) Trial

    Article • Journal of the American College of Cardiology, January 2006, Elsevier

    Professor Jens Flensted Lassen, Kari Saunamaki

  65. Percutaneous revascularization in acute myocardial infarction due to left main stem occlusion

    Article • Scandinavian Cardiovascular Journal, April 2005, Taylor & Francis

    Kari Saunamaki

  66. Target vessel revascularization following percutaneous coronary intervention. A 10-year report from the Danish Percutaneous Transluminal Coronary Angioplasty Registry

    Article • Scandinavian Cardiovascular Journal, April 2005, Taylor & Francis

    Kari Saunamaki

  67. The prognostic value of pre-discharge exercise testing after myocardial infarction treated with either primary PCI or fibrinolysis: a DANAMI-2 sub-study

    Article • European Heart Journal, November 2004, European Society of Cardiology

    Kari Saunamaki

  68. Pharmacological modulation of the ATP sensitive potassium channels during repeated coronary occlusions: no effect on myocardial ischaemia or function

    Article • Heart, April 2004, BMJ

    Kari Saunamaki

  69. Quantitative analysis of dobutamine–atropine stress echocardiography

    Article • European Journal of Echocardiography, September 2003, European Society of Cardiology

    Kari Saunamaki

  70. Randomized Evaluation of Polytetrafluoroethylene-Covered Stent in Saphenous Vein Grafts

    Article • Circulation, July 2003, Wolters Kluwer Health

    Kari Saunamaki

  71. Heparin-Coated Stent Placement for the Treatment of Stenoses in Small Coronary Arteries of Symptomatic Patients

    Article • Circulation, March 2003, Wolters Kluwer Health

    Kari Saunamaki

  72. Low restenosis rate of the NIR coronary stent: Results of the Danish multicenter stent study (DANSTENT)—a randomized trial comparing a first-generation stent with a second-generation stent

    Article • American Heart Journal, February 2003, Elsevier

    Kari Saunamaki

  73. WITHDRAWN: Quantitative Analysis of Dobutamine-Atropine Stress Echocardiography

    Article • European Journal of Echocardiography, January 2003, Oxford University Press (OUP)

    Kari Saunamaki

  74. Effect of early revascularisation in cardiogenic shock complicating acute myocardial infarction. A single center experience

    Article • European Journal of Heart Failure, January 2003, Wiley

    Kari Saunamaki

  75. Quantitative Analysis of Dobutamine–Atropine Stress Echocardiography by Fractional Area Change

    Article • European Journal of Echocardiography, September 2002, Oxford University Press (OUP)

    Kari Saunamaki

  76. Article • January 2002, Springer Science + Business Media

    Kari Saunamaki

  77. Yield of 5,536 Diagnostic Coronary Arteriographies: Results from a Data Registry

    Article • Cardiology, January 2002, Karger Publishers

    Kari Saunamaki

  78. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors

    Article • Journal of the American College of Cardiology, November 2001, Elsevier

    Kari Saunamaki

  79. Health related quality of life after conservative or invasive treatment of inducible postinfarction ischaemia

    Article • Heart, November 2000, BMJ

    Kari Saunamaki

  80. Atrioventricular plane motion during dobutamine-atropine stress echocardiography: The biphasic response in healthy subjects revisited

    Article • Journal of the American Society of Echocardiography, October 2000, Elsevier

    Kari Saunamaki

  81. Article • January 2000, Springer Science + Business Media

    Kari Saunamaki

  82. Evolving non-Q wave versus Q wave myocardial infarction after thrombolysis: A high risk population benefitting from early revascularization. A DANAMI substudy

    Article • Journal of Electrocardiology, January 2000, Elsevier

    Kari Saunamaki

  83. Percutaneous Transradial Coronary Angiography and Angioplasty in Patients with Occlusive Atherosclerotic Iliofemoral Disease

    Article • Scandinavian Cardiovascular Journal, January 2000, Taylor & Francis

    Kari Saunamaki

  84. Cardiac Arrest During Exercise: Anomalous Left Coronary Artery from the Pulmonary Trunk

    Article • Scandinavian Cardiovascular Journal, January 1999, Taylor & Francis

    Kari Saunamaki

  85. Continuous Monitoring of Global Left Ventricular Ejection Fraction During Percutaneous Transluminal Coronary Angioplasty 11This study was supported by the Danish Heart Foundation, Copenhagen, Denmark; and the Laerdal Foundation for Acute Medicine, Stav...

    Article • The American Journal of Cardiology, April 1998, Elsevier

    Kari Saunamaki

  86. Significance and management of early graft failure after coronary artery bypass grafting Feasibility and results of acute angiography and re-re-vascularization

    Article • European Journal of Cardio-Thoracic Surgery, December 1997, Oxford University Press (OUP)

    Kari Saunamaki

  87. Danish Multicenter Randomized Study of Invasive Versus Conservative Treatment in Patients With Inducible Ischemia After Thrombolysis in Acute Myocardial Infarction (DANAMI)

    Article • Circulation, August 1997, Wolters Kluwer Health

    Kari Saunamaki

  88. Echocardiographic Assessment of Regional and Global Left Ventricular Function: Wall-Motion Scoring in Parasternal and Apical Views Versus Apical Views Alone

    Article • Echocardiography, July 1997, Wiley

    Kari Saunamaki

  89. Dobutamine-Atropine Stress Echocardiography in Asymptomatic Healthy Individuals

    Article • Circulation, December 1995, Wolters Kluwer Health

    Kari Saunamaki

  90. Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty

    Article • American Heart Journal, July 1995, Elsevier

    Kari Saunamaki

  91. The diagnostic value of exercise echocardiography in ischemic heart disease in relation to quantitative coronary arteriography

    Article • The International Journal of Cardiovascular Imaging, March 1995, Springer Science + Business Media

    Kari Saunamaki

  92. Assessment of coronary artery stenosis pressure gradient by quantitative coronary arteriography in patients with coronary artery disease

    Article • Clinical Physiology and Functional Imaging, January 1994, Wiley

    Kari Saunamaki

  93. Reproducibility of cardiac volume measurements including left ventricular mass determined by MRI,

    Article • Clinical Physiology and Functional Imaging, November 1993, Wiley

    Kari Saunamaki

  94. Recovery of pulmonary diffusing capacity after maximal exercise

    Article • Journal of Sports Sciences, December 1992, Taylor & Francis

    Kari Saunamaki

  95. Coronary heart disease in young age associated with essential thrombocythemia

    Article • American Heart Journal, July 1992, Elsevier

    Kari Saunamaki

  96. A comparison of electrocardiographic QRS changes and two-dimensional echocardiographic left ventricular wall motion predischarge and in the 4th year following first acute myocardial infarction

    Article • Journal of Electrocardiology, January 1992, Elsevier

    Kari Saunamaki

  97. Effect of intravenous streptokinase on the relation between initial ST-predicted size and final QRS-estimated size of acute myocardial infarcts

    Article • Journal of the American College of Cardiology, November 1990, Elsevier

    Kari Saunamaki

  98. ECG and enzymatic indicators of therapeutic success after intravenous streptokinase for acute myocardial infarction

    Article • American Heart Journal, September 1990, Elsevier

    Kari Saunamaki

  99. Determinants of atrial natriuretic factor levels in coronary heart disease: significance of central pressures, heart chamber volumes and left ventricular mass

    Article • Journal of Internal Medicine, September 1989, Wiley

    Kari Saunamaki

  100. A comprehensive estimation of acute myocardial infarct size using enzymatic, electrocardiographic and mechanical methods

    Article • The American Journal of Cardiology, June 1987, Elsevier

    Kari Saunamaki

  101. EFFECT OF THE IMIDAZOLINE-DERIVATIVE ST-91 ON HEART RATE AND BLOOD PRESSURE IN HEALTHY MAN

    Article • British Journal of Clinical Pharmacology, June 1974, Wiley

    Kari Saunamaki

  102. Permanent impairment of renal function after methicillin nephropathy.

    Article • BMJ, November 1971, BMJ

    Kari Saunamaki